Protective effects of ambroxol on radiation lung injury in patients with advanced lung cancer

纪勇,叶书高,郑明峰,吴小波,卫栋,何毅军,陈静瑜
DOI: https://doi.org/10.19460/j.cnki.0253-3685.2016.01.009
2016-01-01
Abstract:Objective To investigate the protective effects of ambroxol on radiation lung injury in the patients with advanced lung cancer .Methods A total of 120 patients with locally advanced lung cancer under radiotherapy was equally randomized into two groups of A (injected daily with ambroxol 90 mg for 20 days ) and B (without ambroxol as the control ) .The expressions of TNF-α and transforming growth factor β1(TGF-β1) in plasma were detected with ELISA .The clinical symptoms and pulmonary diffusion function (DLCO ) were tested using high resolving power computed tomography .Results The amplitude in the decrease of DLCO more than 25% was less in group A than that in group B(P<0 .05) .The incidence rate of pulmonary fibrosis after radiotherapy was lower in group A than that in group B ( P<0 .05 ) .Plasma expressions of TNF-α and TGF-β1 after radiotherapy were significantly lower in group A than those in group B[(2.43 ± 0.83)ng/ml vs .(5.62 ±2.64)ng/mland(5.56±1.21)ng/mlvs.(11.83±5.54)ng/ml](P<0.01).Therewerenosevere adverse effects related to the use of ambroxol in hepatic or renal damages in both groups .Conclusion Ambroxol may reduce the radiation lung injury possibly via inhibiting the increases of TGF-β1 and TNF-αexpressions in the patients with advanced lung cancer .
What problem does this paper attempt to address?